Form 4: Avenue Therapeutics Director Acquires Stock Options
SEC Form 4 Filing
Director Neil Herskowitz acquired 30,000 employee stock options in Avenue Therapeutics, Inc.
Summary
- Neil Herskowitz, a director of Avenue Therapeutics, Inc., acquired 30,000 employee stock options on September 23, 2024.
- The exercise price of these options is $2.46.
- The options vest in three equal installments on January 1, 2025, January 1, 2026, and January 1, 2027.
- The options expire on September 23, 2034.
- Following the transaction, Herskowitz directly owns 30,000 derivative securities.
Sentiment
Score: 6
Explanation: The sentiment is neutral. It's a routine transaction, but director ownership can be viewed slightly positively.
Positives
- The acquisition of stock options by a director can be seen as a positive sign, indicating confidence in the company's future performance.
Industry Context
This is a standard SEC Form 4 filing, reflecting a change in beneficial ownership of securities. It's common for directors and officers to receive stock options as part of their compensation.
Stakeholder Impact
- The transaction could have a minor positive impact on shareholder sentiment, as it signals confidence from a company director.
Key Dates
| Date | Description |
|---|---|
| 09/23/2024 | Date of transaction: Neil Herskowitz acquired 30,000 employee stock options. |
| 01/01/2025 | One-third of the acquired stock options vest. |
| 01/01/2026 | One-third of the acquired stock options vest. |
| 01/01/2027 | One-third of the acquired stock options vest. |
| 09/23/2034 | Expiration date of the acquired stock options. |
| 09/25/2024 | Date of filing of the Form 4. |
Keywords
stock options, director, Avenue Therapeutics, ATXI, Form 4, Herskowitz, acquisition
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.